MPOX TRACKER

In a significant step to address Uganda’s worsening Mpox outbreak, the European Commission, through the Health Emergency Preparedness and Response Authority (HERA), has delivered 10,000 doses of the MVABN® vaccine. This shipment, which arrived at Entebbe International Airport, is part of HERA’s broader initiative to combat Mpox across Africa, with over 215,000 doses donated to the Africa CDC.

Uganda has reported more than 1,000 confirmed Mpox cases since the outbreak began in July 2024, with fatalities rising from six to ten. The healthcare system is under considerable strain as the disease continues to spread, particularly in urban and semi-urban areas. Kampala Metropolitan Area is the most affected, accounting for over 60% of infections, including 808 cases and one death in Kampala City alone. Other hotspots include Wakiso, Mukono, and Nakasongola.

Laurent Muschel, HERA’s head, emphasized the importance of cross-continental collaboration in tackling health crises, stating, “Solidarity between continents is essential. We will continue to work with our partners to ensure the protection of vulnerable populations through Team Europe’s global response.” This delivery follows earlier vaccine shipments to the Democratic Republic of Congo and Rwanda.

Mpox, characterized by fever, swollen lymph nodes, and a distinctive rash, has disproportionately affected Uganda’s Kampala Metropolitan Area. The vaccine distribution is expected to curb the outbreak and protect at-risk communities. International health officials and Uganda’s government have highlighted the importance of vaccines as a critical tool in containing the spread of the disease.

This intervention by the European Commission and HERA reflects a commitment to global health security, demonstrating that coordinated international efforts are crucial in addressing health emergencies, mitigating their impact, and protecting lives in vulnerable regions.